Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer|Neutropenia
Interventions: BIOLOGICAL: filgrastim|DRUG: docetaxel|DRUG: epirubicin hydrochloride
Sponsor: NCIC Clinical Trials Group